Charles River Laboratories International, Inc. (CRL) Presents at Morgan Stanley 23rd

Question-and-Answer SessionJames FosterChairman, President & CEO So good to be here, as always. We had a very strong first quarter, which we're really pleased with. We had some pent-up demand by big pharmaceutical companies. So they were very strong in the first quarter. We had a strong second quarter as well just in terms of kind of beating our guidance. And it's a little bit of a tale of 2 cities, big pharmaceutical companies seem -- we have greater stability with them for sure. Same with big biotech and ...